Relinde Lieverse
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 11, 2025
Improving Patient Engagement in Phase 2 Clinical Trials With a Trial-Specific Patient Decision Aid: Development and Usability Study.Iva Halilaj, Relinde Lieverse, Cary Oberije
|Mar 10, 2021
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.Veronica Olivo Pimentel, Damiënne Marcus, Alexander Ma van der Wiel
|Jun 17, 2020
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.Relinde I Y Lieverse, Evert J Van Limbergen, Cary J G Oberije
|May 10, 2020
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer.Relinde I Y Lieverse, Damiënne Marcus, Alexander M A van der Wiel
Pageof 1
Frequent Collaborators
2 joint publications
Ludwig J Dubois
1 joint publications
Evert J Van Limbergen
1 joint publications
Ala Yaromina
1 joint publications
Iva Halilaj
1 joint publications
Cary Oberije
1 joint publications
Lizza Hendriks
1 joint publications
Charlotte Billiet
1 joint publications
Ines Joye
1 joint publications
Brice Van Eeckhout
1 joint publications
Anke Wind
